Magnetic Beads Market Report 2025

The magnetic beads market size has grown rapidly in recent years. It will grow from $2.43 billion in 2024 to $2.73 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to the COVID-19 pandemic, increased healthcare expenditure, and rapid growth in the elderly population.

The magnetic beads market size is expected to see rapid growth in the next few years. It will grow to $4.73 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to government initiatives for genetic and microbiological research, growth in the medical technology sector, and the increasing prevalence of chronic diseases. Major trends in the forecast period include developing new technological solutions, focusing on the launch of magnetic bead modification services to enhance cell isolation, RNA or DNA extraction, and protein purification, and introducing magnetic bead separation plates for cost-efficient nucleic acid testing.

Government initiatives focused on genetic and microbiological research are likely to drive the growth of the magnetic beads market during the forecast period. Various countries are adopting national strategies to integrate advanced microbial genomics research, which is expected to boost the demand for magnetic beads used in genetics and microbiological studies. For example, in December 2022, the Department of Health and Social Care, a UK-based government department, reported that NHS England announced its data for a research and development program in March 2022, which could involve up to £18 million ($19.41 million) in funding, subject to government approval. This funding is intended to enhance the use of genomics and related health data for research and innovation within the Genome UK initiative. Thus, supportive government initiatives for genetic and microbiological research are anticipated to foster growth in the magnetic beads market.

The increasing prevalence of chronic diseases is set to serve as a catalyst for the magnetic beads market. Chronic diseases encompass a broad range of conditions lasting one year or more, necessitating ongoing medical attention, limiting daily activities, or both. Given the rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases, there is a heightened demand for advanced diagnostic technologies employing magnetic beads for cost-effective and efficient diagnosis. The use of magnetic beads streamlines the diagnostic process by eliminating the need for vacuum or centrifugation, thereby reducing stress on the target molecules. This method also entails fewer steps and reagents. For instance, according to the World Health Organization's data in September 2023, approximately 74% of the 41 million global deaths were attributed to non-communicable diseases (NCDs) or chronic diseases annually. The breakdown included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2 million deaths from diabetes. Hence, the rising prevalence of chronic diseases is poised to be a significant driver for the magnetic beads market in the forecast period.

Technological advancement stands out as a prominent trend gaining momentum in the magnetic beads market, with key players focusing on innovation and expanding the applications of magnetic beads to secure a larger market share. An illustrative example is Thermo Fisher Scientific Inc., a US-based healthcare company renowned for developing and manufacturing reagents, kits, consumables, and testing kits. In October 2022, Thermo Fisher Scientific Inc. is set to unveil Dynabeads Technology. This innovative technology features paramagnetic spherical polymer particles and finds primary applications in messenger RNA (mRNA) synthesis and purification for manufacturing and vaccine development, as well as carboxylic acid for RNA purification solutions.

Market players in the magnetic beads segment are introducing microplates, specifically magnetic bead separation plates, to facilitate cost-efficient nucleic acid testing. Magnetic beads play a crucial role in nucleic acid extraction processes. Compared to column extraction, magnetic bead-based nucleic acid extraction reagents demonstrate enhanced compatibility with automation systems. This compatibility addresses the increasing demands for high efficiency and reliability in large-scale nucleic acid testing. For instance, in July 2022, Porvair Sciences, a UK-based manufacturer specializing in consumables, porous plastics (Vyon), and instruments for life science and analytical laboratories, launched a 96-well deep well microplate tailored for labs utilizing magnetic beads in applications such as nucleic acid purification, clean-up, and protein purifications. The 96-well magnetic bead separation plate features a reinforced base capable of routine centrifugation at up to 6,000 x g, facilitating faster magnetic bead separation protocols and enhancing sample quality.

In August 2022, BIC, a leading company based in France renowned for its stationery, lighters, and shavers, completed the acquisition of Advanced Magnetic Interaction for an undisclosed amount. This strategic move reinforces BIC's research and development capabilities, particularly in the realm of Digital Expression - a key focus area of BIC's Horizon strategic plan. The acquisition is expected to accelerate the deployment of Advanced Magnetic Interaction's patented technology, with a particular emphasis on B2B activities in Digital Creative and Consumer Electronics applications.

Major companies operating in the magnetic beads market include Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories, Inc, Qiagen, Danaher Corporation, Miltenyi Biotec, Promega Corporation, Takara Bio Inc, Genscript Biotech Corporation, Bangs Laboratories Inc, Zhejiang Orient Gene Biotech Co. Ltd, Eurofins Abraxis, Zeesan Biotech, Hemotune AG, NanoSyrinx, Pulmobiotics S. L, EnginZyme, Chain Biotech, Nuclera Nucleics, Phytoform Labs, Entelechon GmbH, Sloning BioTechnology GmbH, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o, Roche, Spherotech, CardioGenics, NEB, Rockland Immunochemicals.

North America was the largest region in the magnetic beads market in 2024. Eastern Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the magnetic beads market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the magnetic beads market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Magnetic beads are devices composed of superparamagnetic iron oxide particles, typically ranging from 20 to 30 nanometers in size. These particles have a functional carboxylic group covering an iron-oxide core, allowing them to bind to biomolecules such as DNA and RNA, enabling quick and effective separation.

The main types of magnetic beads include cells, nucleic acids, peptides, proteins, and others. Protein magnetic beads, for example, are utilized in the purification of epitope-tagged proteins. The magnetic protein purification method allows direct protein purification from cell lysates, eliminating the need for centrifugation and simplifying the purification process. Various magnetic cores, such as superparamagnetic and ferrimagnetic cores, can be employed. Magnetic beads find applications in various areas, including cell separation and expansion, in vitro diagnostic (IVD) assay development, nucleic acid isolation, immunoprecipitation, antibody purification, protein sample preparation, protein purification, and others. Major end-users of magnetic beads include healthcare facilities, individual pathology labs, research labs, and others.

The magnetic beads market research report is one of a series of new reports that provides magnetic beads market statistics, including magnetic beads industry global market size, regional shares, competitors with a magnetic beads market share, detailed magnetic beads market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic beads industry. This magnetic beads market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The magnetic beads market consists of sales of Carboxylate-modified magnetic beads, amine-blocked beads, oligo(dT)-coated magnetic beads, and streptavidin-coated magnetic beads. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.